RegulyzeCryptoxanthin
Cryptoxanthin is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 3 mg/day max. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 3 mg/day max | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Cryptoxanthin
Cryptoxanthin is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical. The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Cryptoxanthin permitted in nutraceuticals under FSSAI (India)?
Cryptoxanthin (listed in the regulation as “Cryptoxanthin / Mesoxanthin”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Cryptoxanthin?
The permitted level recorded for Cryptoxanthin is 3 mg/day max. Limits can vary by product type and market — confirm against the current regulation.
What product category does Cryptoxanthin belong to?
Cryptoxanthin is classified under: Nutraceuticals, Botanicals.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.